Purpose: Midazolam has antinociceptive effects when administered intrathecally, while its effects associated with systemic administration remain controversial. In the present study, the antinociceptive properties of systemically vs intrathecally administered midazolam were investigated in a rat model of thermal and inflammatory pain.
Methods:One hundred seventy-six (n = 8 animals per dose escalation) male Sprague-Dawley rats were instrumented with lumbar intrathecal catheters. Tail withdrawal in response to thermal stimulation, or paw flinching and shaking in response to sc hind paw formalin injection were compared following intrathecal injection of midazolam (1, 3, 10, 30, or 100 µg in 10 µL) or ip administration (3, 30, 300, or 3,000 µg in 300 µL). Saline 10 µL or 300 µL was used as a control. Behavioural side effects and motor disturbance were also examined.Results: Intrathecal administration of midazolam increased tail flick latency dose dependently (P < 0.05) with a 50% effective dose (ED50) of 1.60 µg, whereas ip administration did not increase latency. Both intrathecal and ip routes of administration decreased the number of paw flinches in both phases 1 and 2 of the formalin test (P < 0.05). The ED50s were 1.26 µg [confidence interval (CI), 0.35-3.18 µg], (phase 1) and 1.20 µg (CI, 0.29-3.71 µg), (phase 2) with intrathecal administration, and 11.6 µg (CI, 2.5-19.3 µg), (phase 1) and 52.2 µg (CI, 18.3-102.7 µg), (phase 2) with ip administration.
Conclusion:Systemically administered midazolam induced antinociception for inflammatory pain only, while intrathecal administration elicited antinociceptive effects on both acute thermal and inflammatory-induced pain. (1, 3, 10, 30, or (IC, 0,71 µg), (phase 2) avec l'administration intrathécale et de 11,6 µg (IC,2,[5][6][7][8][9][10][11][12][13][14][15][16][17][18][19]3 µg), (phase 1) et de 52,2 µg (IC,18,7
Objectif : Administré par voie intrathécale, le midazolam a des effets antinociceptifs, mais les effets d'une administration intrapéritonéale (ip) demeurent controversés. Dans la présente étude, nous avons vérifié les propriétés antinociceptives de l'administration générale vs intrathécale du midazolam chez un modèle expéri-mental de douleur thermique et inflammatoire chez le rat.
Méthode : Un cathéter intrathécal lombaire a été mis en place chez 176 (n = 8 animaux par dose croissante) rats mâles SpragueDawley. Le retrait de la queue, en réaction à la stimulation thermique, ou le tressaillement et le tremblement de la patte en réaction à l'injection sc de formaline dans la patte arrière, ont été comparés à la suite d'une injection intrathécale de midazolam